Incidence, management, and course of cancer in patients with inflammatory bowel disease.
about
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.Cellular and molecular effects of yeast probiotics on cancer.Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.
P2860
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@en
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@nl
type
label
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@en
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@nl
prefLabel
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@en
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
@nl
P2093
P2860
P50
P356
P1476
Incidence, management, and course of cancer in patients with inflammatory bowel disease
@en
P2093
Alicia Algaba
Begoña Casis
Carlos Taxonera
Daniel Martín-Rodríguez
Elvira Quintanilla
Fernando Bermejo
Ignacio Marín-Jiménez
Ignacio Moral
Iván Guerra
Luis Menchén
P2860
P304
P356
10.1093/ECCO-JCC/JJV032
P577
2015-02-16T00:00:00Z